Piper Jaffray Companies Weighs in on Henry Schein, Inc.’s FY2019 Earnings (HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Piper Jaffray Companies increased their FY2019 earnings per share (EPS) estimates for Henry Schein in a research note issued on Tuesday, November 6th. Piper Jaffray Companies analyst S. James now forecasts that the company will earn $4.49 per share for the year, up from their previous forecast of $4.47. Piper Jaffray Companies also issued estimates for Henry Schein’s Q1 2020 earnings at $1.13 EPS, Q2 2020 earnings at $1.17 EPS, Q3 2020 earnings at $1.20 EPS and FY2020 earnings at $4.83 EPS.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 6th. The company reported $1.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.02. Henry Schein had a net margin of 3.00% and a return on equity of 20.40%. The business had revenue of $3.28 billion for the quarter, compared to analyst estimates of $3.37 billion. During the same quarter last year, the business earned $0.87 earnings per share. The company’s revenue for the quarter was up 3.8% compared to the same quarter last year.

HSIC has been the topic of several other research reports. BidaskClub lowered shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 23rd. Barrington Research reiterated a “buy” rating and issued a $92.00 target price on shares of Henry Schein in a research report on Tuesday, August 7th. ValuEngine upgraded shares of Henry Schein from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 13th. Stifel Nicolaus boosted their price target on shares of Henry Schein from $76.00 to $81.00 and gave the stock a “hold” rating in a research report on Tuesday, August 7th. Finally, Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $86.00 price target on the stock in a research report on Wednesday, July 25th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $84.41.

Shares of NASDAQ HSIC opened at $86.97 on Thursday. Henry Schein has a 52-week low of $62.56 and a 52-week high of $90.52. The stock has a market capitalization of $12.79 billion, a PE ratio of 24.16, a P/E/G ratio of 2.56 and a beta of 0.87. The company has a current ratio of 1.30, a quick ratio of 0.68 and a debt-to-equity ratio of 0.29.

A number of institutional investors and hedge funds have recently bought and sold shares of HSIC. McAdam LLC acquired a new position in Henry Schein in the 3rd quarter valued at about $104,000. NEXT Financial Group Inc acquired a new position in Henry Schein in the 3rd quarter valued at about $103,000. Squar Milner Financial Services LLC acquired a new position in Henry Schein in the 2nd quarter valued at about $120,000. Piedmont Investment Advisors LLC acquired a new position in Henry Schein in the 2nd quarter valued at about $130,000. Finally, Whitener Capital Management Inc. acquired a new position in Henry Schein in the 3rd quarter valued at about $160,000.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Story: Why do companies engage in swaps?

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply